ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2009 028 483.5, EP file number: 13 00 2793.1 (Designation/title: Verwendung von zelldurchlässigen Peptidhemmern des JNK-Signaltransduktionsweges zur Behandlung verschiedener Krebs-Erkrankungen)

↩ Details

Tabular representation
Current state: Not active, Current state: Termination likely/termination

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Oct 16, 2013Oct 16, 2013 Filing
2 Q10 Document published Nov 28, 2013Nov 28, 2013Nov 28, 2013 Filing
3 Q10 Document published Dec 17, 2014Dec 17, 2014 Examination
4 Q10 Document published Feb 5, 2015Feb 5, 2015Feb 5, 2015 Examination
5 F10 IP right granted Sep 18, 2015Sep 18, 2015Dec 31, 2015 Grant
6 H10 IP right ceased Jan 3, 2018Jan 3, 2018Mar 29, 2018 Termination likely/termination
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Oct 16, 2013Oct 16, 2013 Filing
2 Q10 Document published Nov 28, 2013Nov 28, 2013Nov 28, 2013 Filing
3 P22 Classification modified May 23, 2014May 23, 2014 Filing
4 Q10 Document published Dec 17, 2014Dec 17, 2014 Examination
5 Q10 Document published Feb 5, 2015Feb 5, 2015Feb 5, 2015 Examination
6 F10 IP right granted Sep 18, 2015Sep 18, 2015Dec 31, 2015 Grant
7 H13 IP right lapsed Jan 3, 2018Jan 3, 2018Mar 29, 2018 Termination likely/termination

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data